Can a text message therapy ease dementia-related mood issues?
NCT ID NCT07332624
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether automated instant messages can help manage neuropsychiatric symptoms like depression and anxiety in people with mild cognitive impairment (MCI). Forty adults aged 50 and older with MCI will receive an 8-week program of guided messages based on acceptance and commitment therapy. The goal is to see if this approach is feasible and can reduce symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
automated instant message-guided therapy (acceptance and commitment therapy)
What this could lead to
If it works, this could offer a low-cost, accessible way to ease mood and behavioral symptoms in people with mild cognitive impairment.
What could go wrong
This is a very small pilot study (40 people) with no control group comparison yet. The intervention is delivered by automated messages, which may not be as effective as in-person therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong
Hong Kong, Hong Kong